Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease

Grasse, France and Leiden, the Netherlands – 11 December 2024 – Phenocell SAS (part of Axol Bioscience) a leading provider of stem cell-derived models and services, and Amarna Therapeutics, a biotechnology pioneer in innovative gene therapies, are pleased to announce that their joint project AMD-HALT has been awarded with a prestigious Eurostars grant. This funding by Eurostars will support their collaboration to validate Amarna's patented gene therapy platform using a novel and advanced cellular disease ...